Neurogenic ED
Neurogenic Erectile and Ejaculatory Dysfunction: Mechanisms and Lesion Patterns
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (clinical category, not a product)
Reference only. Not medical advice.
What can go wrong
The principal risk in this category is mismanagement from ignoring lesion level: prescribing and abandoning a PDE5 inhibitor without recognizing that response is predictable from the lesion, and missing autonomic dysreflexia in high spinal lesions, which is a hypertensive emergency. Neurogenic ED frequently coexists with cardiovascular disease (especially in diabetes), so it should prompt systemic evaluation rather than isolated symptomatic treatment.
This is something to take to a clinician. The Atlas can tell you what is known about neurogenic ed in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Neurogenic ED encompasses erectile and ejaculatory failure caused by disease or injury anywhere along the neural pathways that control the penis, from cortex to cavernous nerves. Two physiologically distinct erectile circuits exist: a reflexogenic (reflex) pathway mediated by the sacral parasympathetic outflow (S2-S4 via the pelvic and cavernous nerves) and a psychogenic pathway descending from supraspinal centers through the thoracolumbar sympathetic outflow (T11-L2). Because these pathways enter the cord at different levels, the clinical pattern depends heavily on lesion site: a high spinal lesion can abolish psychogenic but preserve reflexogenic erections, while a sacral/conus lesion does the reverse. Ejaculation, a coordinated sympathetic (emission) and somatic (expulsion) event, is frequently impaired even when erection is preserved.
Erection is a spinal reflex with two parallel wiring systems, lesion location, not just lesion presence, determines the pattern.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
- Diagnostic anchor
- Distinguishes neurogenic from vasculogenic, hormonal, and psychogenic ED
- Treatment selection
- Lesion level predicts PDE5 responsiveness and need for injection/implant
How it works
Penile erection is ultimately a vascular event driven by parasympathetic nitric-oxide release from cavernous nerve terminals and endothelium, relaxing trabecular smooth muscle so the corpora cavernosa engorge. The sacral parasympathetic nucleus (S2-S4) is the engine of the reflexogenic erection, triggered by direct genital tactile stimulation via the pudendal nerve afferents and a sacral reflex arc that does not require the brain. The psychogenic erection originates supraspinally (from visual, auditory, fantasy or olfactory input processed in the medial preoptic area, paraventricular nucleus and limbic system) and descends to recruit both the thoracolumbar sympathetic outflow (which can mediate erection when the sacral center is destroyed) and the sacral center. Sympathetic tone is generally pro-detumescence (noradrenergic), so the autonomic balance is delicate.
Why the SAME lesion produces opposite patterns
Clinicians often say 'nerve damage causes ED' as if the relationship were uniform. It is not. In upper-motor-neuron (UMN) lesions above the sacral cord, the sacral reflex arc is intact and disinhibited, so reflexogenic erections are PRESERVED or even exaggerated, but they are involuntary, often poorly sustained, and disconnected from arousal. In lower-motor-neuron (LMN) lesions involving the conus/cauda equina (S2-S4) or the cavernous nerves themselves, the reflex arc is destroyed and reflexogenic erections are LOST; only the psychogenic pathway (if the thoracolumbar outflow survives) can produce a typically weaker erection. This dichotomy, characterized in the classic spinal-cord-injury literature (Bors and Comarr's foundational 1960 series), is the single most useful predictor of erectile capacity and treatment response.
What people get wrong
Often saidAny spinal injury means no erections
ActuallyMost men with complete UMN spinal lesions retain reflexogenic erections; the problem is they are involuntary and hard to sustain, not absent.
Often saidNeurogenic ED is untreatable
ActuallyLesion-dependent. PDE5 inhibitors work well in many incomplete or UMN lesions, and intracavernosal injection and penile implants are effective across nearly all neurogenic causes.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Modern understanding of neurogenic erection began with war-injury cohorts. The systematic correlation of lesion level with sexual function was established by Bors and Comarr in their landmark 1960 analysis of spinal-cord-injured veterans, which remains the conceptual scaffold for the field. Subsequent neurophysiology (Courtois, Sipski, others) refined the segmental map.
Set against the alternatives
Unlike vasculogenic ED (arterial/endothelial) or hormonal ED (low testosterone), neurogenic ED is defined by the integrity of the conduction pathway rather than the end organ. It often coexists with vasculogenic disease (e.g., diabetes injures both nerves and vessels), which is why pure categories are clinical idealizations.
What we do not know
- How reliably can residual psychogenic pathways be identified at the bedside?
- Can neuromodulation restore voluntary control of the sacral reflex?
At a glance
- Reflexogenic center
- Sacral S2-S4 (parasympathetic)
- Psychogenic center
- Thoracolumbar T11-L2 (sympathetic)
- Final common mediator
- Cavernous nerves / nitric oxide
- Ejaculation
- T10-L2 emission + S2-S4 somatic expulsion
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Neurogenic ED. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Bors and Comarr, spinal cord injury sexual function series1960
Foundational correlation of lesion level (UMN vs LMN, complete vs incomplete) with preserved reflexogenic vs psychogenic erection and ejaculatory capacity
Courtois and colleagues, neurophysiology of SCI sexual responses1990s-2010s
Detailed the segmental control of erection and ejaculation and the role of residual pathways